Take a Dose of Express Scripts
Market turmoil creates short-term opportunities for long-term investors, and a great example of this can be found in Express Scripts (ESRX). The company is among the largest pharmacy benefit managers in North America, having generated more than $46 billion in 2011 sales.
On April 1, Express Scripts closed on its $29.1 billion merger with Medco Health, and it sees $1 billion in annual cost savings once the companies are fully integrated. Expectations also have the merger becoming accretive in the very first year. Analysts are now looking for earnings per share of $3.53 and $4.30 for 2012 and 2013, respectively. Both of these, if achieved, would represent new all-time EPS highs....275 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.